Skip header and navigation

Refine By

10 records – page 1 of 1.

Source
Lakartidningen. 1989 Dec 20;86(51):4507-8
Publication Type
Article
Date
Dec-20-1989
Author
J. Ahlmén
Source
Lakartidningen. 1989 Dec 20;86(51):4507-8
Date
Dec-20-1989
Language
Swedish
Publication Type
Article
Keywords
Health services needs and demand
Humans
Sweden
Uremia - therapy
PubMed ID
2601520 View in PubMed
Less detail

Clinical aspects of continuous ambulatory peritoneal dialysis.

https://arctichealth.org/en/permalink/ahliterature48919
Source
Scand J Urol Nephrol Suppl. 1983;72:1-46
Publication Type
Article
Date
1983
Author
N. Grefberg
Source
Scand J Urol Nephrol Suppl. 1983;72:1-46
Date
1983
Language
English
Publication Type
Article
Keywords
Anti-Bacterial Agents - therapeutic use
Catheters, Indwelling
Diabetic Nephropathies - therapy
Humans
Hydrothorax - etiology
Netilmicin - therapeutic use
Peritoneal Dialysis - adverse effects
Peritoneal Dialysis, Continuous Ambulatory - adverse effects
Peritonitis - drug therapy - etiology
Research Support, Non-U.S. Gov't
Staphylococcal Infections - drug therapy - etiology
Sweden
Time Factors
Uremia - therapy
Abstract
Clinical aspects of Continuous Ambulatory Peritoneal Dialysis (CAPD) were studied in the first fifty patients started on CAPD at our hospital. CAPD was found to achieve good control of the uremic symptoms and of the biochemical values studied. Hypertension became less pronounced. The costs were found to be low. Twenty-four diabetic subjects were studied in detail. Intraperitoneal administration of insulin resulted in good metabolic control of the diabetes. The two catheters used for peritoneal access were compared. Because of problems related to the removal of the Toronto Western Hospital catheter it was concluded that the Tenckhoff catheter was to be preferred. Peritonitis was found to be the worst complication. Coagulase negative staphylococci accounted for 57% of the cases. During the study an increasing percentage of infections were caused by bacteria with multiple resistance to antibiotics. Netilmicin, a new aminoglycoside, was evaluated for the treatment of CAPD-related peritonitis. 84% of the cases responded. One of the nineteen patients treated sustained reversible vestibular toxicity. No other side effects were noted. In two patients right-sided hydrothorax was found to be a complication of peritoneal dialysis. In one case it was demonstrated that defects in the right diaphragm was the cause of the complication. In the other CAPD was continued despite the complication.
PubMed ID
6577582 View in PubMed
Less detail

Conversion from conventional to nocturnal hemodialysis improves vitamin D levels.

https://arctichealth.org/en/permalink/ahliterature164366
Source
Kidney Int. 2007 Jun;71(11):1172-6
Publication Type
Article
Date
Jun-2007
Author
S J Nessim
S V Jassal
S V Fung
C T Chan
Author Affiliation
Department of Medicine, Division of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Source
Kidney Int. 2007 Jun;71(11):1172-6
Date
Jun-2007
Language
English
Publication Type
Article
Keywords
25-Hydroxyvitamin D 2 - blood
Adult
African Continental Ancestry Group - statistics & numerical data
Asian Continental Ancestry Group - statistics & numerical data
Calcitriol - blood
Canada
Circadian Rhythm
Cohort Studies
European Continental Ancestry Group - statistics & numerical data
Female
Humans
Longitudinal Studies
Male
Middle Aged
Phosphorus - blood
Prospective Studies
Renal Dialysis
Uremia - therapy
Vitamin D - blood
Abstract
Patients on conventional hemodialysis have low levels of 25-hydroxy-vitamin D probably due to diet and decreased cutaneous synthesis. As 1,25 dihydroxy-vitamin D synthesis is substrate-dependent in end-stage renal disease, this could be a contributing factor to low 1,25 dihydroxy-vitamin D levels in patients undergoing conventional hemodialysis. We converted 35 patients historically on conventional hemodialysis to nocturnal hemodialysis for a minimum of 6 months thereby significantly increasing sessional equilibrated Kt/V from an average of 1.30 to an average of 2.01. Dietary restrictions were also removed. Serum phosphorus significantly fell, whereas the serum calcium, parathyroid hormone, and the mean dose of calcitriol did not change after the conversion. Significant increases in both 25-hydroxy and 1,25-dihydroxy-vitamin D levels were seen after hemodialysis mode conversion. A significant correlation was found between the dialysis dose and the levels of both hydroxylated forms of vitamin D. We suggest that improving uremia by nocturnal hemodialysis in the absence of exogenous supplementation is associated with increased 25 and 1,25-hydroxy-vitamin D levels. Additionally, normalization of serum phosphorus may improve 1alpha-hydroxylation thereby enhancing substrate-dependent generation of 1,25-dihydroxy-vitamin D in chronic dialysis patients.
PubMed ID
17396116 View in PubMed
Less detail

[Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization].

https://arctichealth.org/en/permalink/ahliterature208498
Source
Nord Med. 1997 May;112(5):154-62
Publication Type
Article
Date
May-1997
Author
V. Koivisto
P H Groop
N P Huttunen
J. Kivekäs
A. Pasternack
M. Uusitupa
J. Viikari
Author Affiliation
Medicinska kliniken, Helsingfors Universitetscentralsjukhus.
Source
Nord Med. 1997 May;112(5):154-62
Date
May-1997
Language
Swedish
Publication Type
Article
Keywords
Adolescent
Albuminuria - urine
Child
Cost of Illness
Diabetes Mellitus, Type 1 - physiopathology
Diabetes Mellitus, Type 2 - physiopathology
Diabetic Nephropathies - diagnosis - economics - physiopathology - therapy
Dietary Proteins
Female
Finland
Humans
Hyperglycemia - therapy
Hypertension, Renal - therapy
Hypoglycemic agents - therapeutic use
Hypolipidemic Agents - therapeutic use
Kidney Diseases - complications
Pregnancy
Uremia - therapy
Abstract
Owing to advances in the diagnosis and treatment of diabetic nephropathy, its management has become more active and is now initiated earlier after the presence of microalbuminuria has been established. In 1996 the Finnish Diabetic Association's nephropathy group issued recommendations concerning screening for diabetic nephropathy, and treatment and follow-up of patients with the disease.
PubMed ID
9273505 View in PubMed
Less detail

[Do patients with uremia receive sufficient health care? Varying estimations of the need for dialysis]

https://arctichealth.org/en/permalink/ahliterature73823
Source
Lakartidningen. 1989 Dec 20;86(51):4514-9
Publication Type
Article
Date
Dec-20-1989

[Intermittent hemodialysis in terminal chronic nephropathy in Fredericia Hospital].

https://arctichealth.org/en/permalink/ahliterature110176
Source
Ugeskr Laeger. 1969 Mar 20;131(12):511-9
Publication Type
Article
Date
Mar-20-1969

Predicting future trends in the number of patients on renal replacement therapy in Denmark.

https://arctichealth.org/en/permalink/ahliterature207413
Source
Nephrol Dial Transplant. 1997 Oct;12(10):2117-23
Publication Type
Article
Date
Oct-1997
Author
P. Vestergaard
H. Løkkegaard
Author Affiliation
Danish National Registry, Danish Society of Nephrology.
Source
Nephrol Dial Transplant. 1997 Oct;12(10):2117-23
Date
Oct-1997
Language
English
Publication Type
Article
Keywords
Adult
Denmark
Forecasting
Humans
Kidney Transplantation
Middle Aged
Models, Theoretical
Prognosis
Renal Replacement Therapy - trends
Stochastic Processes
Uremia - therapy
Abstract
To predict the future prevalence of patients on renal replacement therapy due to chronic renal failure in Denmark.
Four thousand and nine terminal uraemic patients (median age 50.0 years, 15.2% diabetic) were treated in Denmark with renal replacement therapy in the period 1 January 1991 to 31 December 1995. Incidence rates and rates of transition between the treatment modalities (haemodialysis, peritoneal dialysis, and renal transplantation) were calculated. The prediction was made using a Markov model in three ways: (1) using the average rates (deterministic model), (2) using rates simulated with pseudorandom numbers based on the average rates (stochastic model), and (3) using increasing incidence rates in a deterministic model.
Using present rates both model types predicted a significant increase in the prevalence of renal transplant recipients or = 60 years (from 456 in 1995 to about 903 in 2006) while the prevalence of other treatment modalities would change less dramatically. The overall prevalence proportion would increase from 539 patients per million population (p.m.p.) in 1995 to about 777 p.m.p. in 2006. The stochastic model clearly demonstrated the uncertainties linked to the prognosis in contrast to the deterministic model. The deterministic model with increasing rates predicted a prevalence proportion of 1162 p.m.p. in 2006.
Even with present rates the prevalence of haemodialysis patients in Denmark will continue to increase. Mathematical models offers a good tool to study future trends and to plan future capacity.
PubMed ID
9351075 View in PubMed
Less detail

10 records – page 1 of 1.